The COVID-19 pandemic has brought many changes to the pharmaceutical industry, among them how companies can continue to engage with healthcare professionals (HCPs) and other stakeholders.
When Kay Wesley moved from the world of dot com to work as global digital director at AstraZeneca, she realised that pharma was transforming for digital at a rather different pace.
Our live coverage from this year’s slimmed down, virtual version of the American Society of Clinical Oncology (ASCO) annual meeting begins at 8am (ET).
